EUVIMEDEUVIMED entdecken
Crossref

Lipid‐lowering effect of mangiferin through the inhibition of pancreatic lipase activity

Shuang Wang, Yuan Qin, Yashi Liu, Rui Jiao, Rui Lin, Zongxiang Yuan, Zouyan He iD

Journal of the Science of Food and Agriculture · 30.08.2025 · 105 (11) · 5932-5939

DOI: 10.1002/jsfa.14301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Science of Food and Agriculture, online erschienen am 23.04.2025. Verfasst von Shuang Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Xanthones, Lipase, Pancreas, Hypolipidemic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Guangxi Scientific and Technological Bases and Talents Special Program (GKAD22035053), National Natural Science Foundation of China (32302071, 32272310), Guang…, Guangxi Scientific and Technological Bases and Talents Special Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The inhibition of pancreatic lipase activity to reduce dietary lipid absorption is an effective strategy to combat obesity. Mangiferin, a bioactive flavonoid derived from Mangifera indica , exhibits potent lipid‐lowering potential. However, although its in vitro inhibitory effect on pancreatic lipase has been identified, the underlying mechanism remains poorly understood. Direct in vivo evidence of its impact on dietary lipid absorption is also lacking. This study aimed to elucidate the mechanism of mangiferin's inhibition of pancreatic lipase through in vitro inhibitory kinetics assays and in silico molecular docking analysis. Its effects on dietary lipid absorption were also evaluated in a mouse model of high‐fat diet (HFD)‐induced obesity.

Results

Inhibitory kinetics assays demonstrated that mangiferin inhibited pancreatic lipase in a reversible, non‐competitive manner, with a half‐ maximal inhibitory concentration (IC 50 ) of 82.31 μmol L −1 . Molecular docking showed that mangiferin bound to the enzyme's allosteric site through hydrogen bonds with Glu‐188, Arg‐191, Gln‐22, and Val‐21 residues, consistent with non‐competitive inhibition. In vivo studies revealed that administration of 200 mg kg −1 body weight of mangiferin alleviated HFD‐induced obesity, hepatic steatosis, and hyperlipidemia significantly. Notably, mangiferin increased fecal lipid excretion by 52.5%, which was significant, indicating reduced dietary lipid absorption.

Conclusion

These findings suggest that mangiferin is a promising pancreatic lipase inhibitor, which may reduce dietary lipid absorption, contributing, at least partially, to its lipid‐lowering effects. © 2025 Society of Chemical Industry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

XanthonesLipasePancreasHypolipidemic AgentsObesityEnzyme InhibitorsAnimalsMiceMaleMolecular Docking SimulationDiet, High-FatHumansMice, Inbred C57BLMangiferaPlant ExtractsKinetics

Stichwörter der Autor:innen

lipid absorptionlipid excretionmangiferinobesitypancreatic lipase

Substanzen

mangiferinXanthonesLipaseHypolipidemic AgentsEnzyme InhibitorsPlant Extracts

Autor:innen und Institutionen

  • School of Public Health, Guangxi Medical University, Nanning, China.
  • Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nann…
  • Department of Food Science and Engineering, Institute of Food Safety and Nutrition, Jinan University, Guangzhou, China.

ORCID-Profile: Zouyan He

Förderung

  • Guangxi Scientific and Technological Bases and Talents Special Program (GKAD22035053), National Natural Science Foundation of China (32302071, 32272310), Guang…
  • Guangxi Scientific and Technological Bases and Talents Special Program
  • National Natural Science Foundation of China
  • Guangxi Natural Science Foundation
  • the First-class Discipline Innovation-driven Talent Program of Guangxi Medical University, and Advanced Innovation Teams and Xinghu Scholars Program of Guangxi…
  • Natural Science Foundation of Guangxi Zhuang Autonomous Region

Zitieren

APA

Wang, S., Qin, Y., Liu, Y., Jiao, R., Lin, R., Yuan, Z., & He, Z. (2025). Lipid‐lowering effect of mangiferin through the inhibition of pancreatic lipase activity. Journal of the Science of Food and Agriculture, 105(11), 5932-5939. https://doi.org/10.1002/jsfa.14301

Vancouver

Wang S, Qin Y, Liu Y, Jiao R, Lin R, Yuan Z, et al. Lipid‐lowering effect of mangiferin through the inhibition of pancreatic lipase activity. Journal of the Science of Food and Agriculture. 2025;105(11):5932-5939. doi:10.1002/jsfa.14301

BibTeX
@article{Wang2025,
  author = {Wang, Shuang and Qin, Yuan and Liu, Yashi and Jiao, Rui and Lin, Rui and Yuan, Zongxiang and He, Zouyan},
  title = {Lipid‐lowering effect of mangiferin through the inhibition of pancreatic lipase activity},
  journal = {Journal of the Science of Food and Agriculture},
  year = {2025},
  volume = {105},
  number = {11},
  pages = {5932--5939},
  doi = {10.1002/jsfa.14301}
}
Kostenlos starten →